Novo Nordisk
Pharmaceutical maker of insulin pens and biologic medicines for patients with diabetes, obesity and rare blood disorders
Recent signals
What changed at Novo Nordisk in the last 6 months, newest first. Each line links to its public source.
- 27 Oct 2026 Public contract · Won €50k public contract from Fakultní nemocnice Motol a Homolka: SMLOUVA O KLINICKÉM HODNOCENÍ LÉČIV - NN9490-8037 - použití zenagamtidu ke snížení rizika závažných nežádoucíc smlouvy.gov.cz
- 19 Oct 2026 Public contract · Won €126k public contract from IKEM: Smlouva o klinickém hodnocení léčiv NN9490-8266, HF-POLARIS smlouvy.gov.cz
- 16 Oct 2026 Public contract · Won €154k public contract from Nemocnice České Budějovice, a.s.: Smlouva o klinickém hodnocení léčiv - AMBIENCE NN9490-8037 smlouvy.gov.cz
About Novo Nordisk
The Czech website of Novo Nordisk presents the company's research, development and manufacturing of innovative biologic medicines and drug delivery forms, such as insulin pens, for people with serious chronic diseases. The site names diabetes, obesity and rare blood or endocrine disorders as its focus areas, and says the company also invests in cell-based cure therapies, prevention of type 2 diabetes and digital health solutions.
The website describes its customers as patients with these chronic conditions, reached through therapies sold worldwide. It does not describe its revenue model, distribution partners or customer segments in more detail.
The site mentions a Novo Nordisk site named Bohumil and has a careers section that links to an internal job board; the pages themselves do not list specific open roles. The website is published in Czech.
Product: Insulin pens, biologic medicines and other therapies for diabetes, obesity and rare blood or endocrine disorders.
Public contracts
Contracts Novo Nordisk signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.
Customers
42 contracts with 22 buyers · 30.0M CZK
| Contracts | Value | |
|---|---|---|
| Fakultní nemocnice u sv. Anny v Brně | 3 | 11.8M CZK |
| Nemocnice České Budějovice, a.s. | 2 | 6.3M CZK |
| IKEM | 9 | 4.0M CZK |
| Všeobecná fakultní nemocnice v Praze | 4 | 2.3M CZK |
| Krajská nemocnice T. Bati, a. s. | 1 | 2.1M CZK |
| Fakultní nemocnice Ostrava | 1 | 1.5M CZK |
| Fakultní nemocnice Motol a Homolka | 1 | 1.2M CZK |
| Fakultní nemocnice Královské Vinohrady | 2 | 430k CZK |
Open public tenders for Novo Nordisk →
Suppliers
2 contracts with 2 suppliers · —
| Contracts | Value | |
|---|---|---|
| Zaměstnanecká pojišťovna Škoda | 1 | — |
| Zdravotní pojišťovna ministerstva vnitra České republiky | 1 | — |
Latest contracts
- 3 Nov 2026 for IKEM · Společné prohlášení níže uvedených smluvních stran, ADA 2026, New Orleans, USA · 56k CZK register
- 27 Oct 2026 for Fakultní nemocnice Motol a Homolka · SMLOUVA O KLINICKÉM HODNOCENÍ LÉČIV - NN9490-8037 - použití zenagamtidu ke snížení rizika závažných nežádoucích kardiovaskulárních příhod · 1.2M CZK register
- 19 Oct 2026 for IKEM · Smlouva o klinickém hodnocení léčiv NN9490-8266, HF-POLARIS · 3.1M CZK register
- 16 Oct 2026 for Nemocnice České Budějovice, a.s. · Smlouva o klinickém hodnocení léčiv - AMBIENCE NN9490-8037 · 3.8M CZK register
- 12 Oct 2026 for Všeobecná fakultní nemocnice v Praze · Smlouva o klinickém hodnocení léčiv KH 125/2026 · 1.5M CZK register
- 8 Sep 2026 for Fakultní nemocnice Hradec Králové · sponzorská smlouva - 28.9. – 2.10.2026 - Milano · 69k CZK register
Jobs at Novo Nordisk
Leadership
- Anna Agnieszka Grefkowicz · Jednatel (Managing director)Source: business register
- Adriana Slavíková · ProkuraSource: business register
- Silvie Slatinská · ProkuraSource: business register
More biotech & pharma companies
Octapharma CZ
Plasma-derived and recombinant medicines for patients in hematology, immunotherapy and intensive careNew on EvolcOMEGA PHARMA
Czech distributor of OTC medicines, medical devices, supplements and cosmetics for pharmacies and mass retailNew on EvolcOncoRa
Microbial strain development, recombinant protein production and oral drug formulation services for pharma and biotech clientsNew on EvolcOrifarm Supply
Parallel-import, generic and OTC medicines distributor supplying wholesalers, pharmacies and hospitals across EuropeRemote-friendlyOrion Pharma
Finnish pharmaceutical maker of human and veterinary medicines and active ingredients, with a Prague office for the Czech marketPascoe Česko
Markets Pascoe natural medicine preparations to Czech consumers, with manufacturing by a German group companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Adobe Experience Platform TagsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content delivery
- FastlyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-served-by
- Response headerx-served-by
- Response headerx-served-by
Content management
- Adobe Experience ManagerHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- OneTrustHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.